Share on Facebook
Share on Twitter
Share on LinkedIn

McKesson Corp. (MCK), the largest U.S drug distributor, reached a $151 million settlement with states over claims it caused Medicaid programs to pay too much for prescription drugs.

The agreement resolves allegations that McKesson overbilled states by reporting inflated prices for medications, state attorneys general said today. The deal follows a settlement reached in April with the federal government.

Click here to read more.